These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 8178678)

  • 41. Clinical validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview.
    Kølbæk P; Dines D; Holm T; Blicher AB; Sørensen RD; O'Leary KM; Feller SG; Buus CW; Nielsen CM; Opler M; Mors O; Correll CU; Østergaard SD
    J Psychopharmacol; 2021 Sep; 35(9):1081-1090. PubMed ID: 33779360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia.
    Bressan RA; Chaves AC; Shirakawa I; de Mari J
    Schizophr Res; 1998 Jun; 32(1):41-9. PubMed ID: 9690333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Differential diagnosis of borderline in relation to schizophrenic and neurotic depressive disorders].
    Eckert J; Papenhausen R; Biermann-Ratjen EM; Wuchner M
    Psychother Psychosom Med Psychol; 1991 Aug; 41(8):320-7. PubMed ID: 1946904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.
    Miller TJ; McGlashan TH; Rosen JL; Cadenhead K; Cannon T; Ventura J; McFarlane W; Perkins DO; Pearlson GD; Woods SW
    Schizophr Bull; 2003; 29(4):703-15. PubMed ID: 14989408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improvement of inter-rater reliability of PANSS items and subscales by a standardized rater training.
    Müller MJ; Wetzel H
    Acta Psychiatr Scand; 1998 Aug; 98(2):135-9. PubMed ID: 9718240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Schizophrenic patients with depression: psychopathological profiles and relationship with negative symptoms.
    Lindenmayer JP; Grochowski S; Kay SR
    Compr Psychiatry; 1991; 32(6):528-33. PubMed ID: 1778080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reliability of a standardized and expanded Brief Psychiatric Rating Scale: a replication study.
    Hafkenscheid A
    Acta Psychiatr Scand; 1993 Nov; 88(5):305-10. PubMed ID: 8296573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients].
    Peralta Martín V; Cuesta Zorita MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(4):171-7. PubMed ID: 7810373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specificity of the Calgary Depression Scale for schizophrenics.
    Addington D; Addington J; Maticka-Tyndale E
    Schizophr Res; 1994 Feb; 11(3):239-44. PubMed ID: 8193062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The diagnoses of schizophrenia, schizoaffective disorder, bipolar disorder and unipolar depression: interrater reliability and congruence between DSM-IV and ICD-10.
    Cheniaux E; Landeira-Fernandez J; Versiani M
    Psychopathology; 2009; 42(5):293-8. PubMed ID: 19609099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.
    Addington D; Addington J; Atkinson M
    Schizophr Res; 1996 May; 19(2-3):205-12. PubMed ID: 8789919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reliability and validity of a depression rating scale for schizophrenics.
    Addington D; Addington J; Maticka-Tyndale E; Joyce J
    Schizophr Res; 1992 Mar; 6(3):201-8. PubMed ID: 1571313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reliability and validity of the positive and negative syndrome scale for schizophrenics.
    Kay SR; Opler LA; Lindenmayer JP
    Psychiatry Res; 1988 Jan; 23(1):99-110. PubMed ID: 3363019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia.
    El Yazaji M; Battas O; Agoub M; Moussaoui D; Gutknecht C; Dalery J; d'Amato T; Saoud M
    Schizophr Res; 2002 Jul; 56(1-2):121-7. PubMed ID: 12084426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new rating scale for negative symptoms: the Motor-Affective-Social Scale.
    Trémeau F; Goggin M; Antonius D; Czobor P; Hill V; Citrome L
    Psychiatry Res; 2008 Sep; 160(3):346-55. PubMed ID: 18722021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural differences within negative and depressive syndrome dimensions in schizophrenia, organic brain disease, and major depression: A confirmatory factor analysis of the positive and negative syndrome scale.
    Eisenberg DP; Aniskin DB; White L; Stein JA; Harvey PD; Galynker II
    Psychopathology; 2009; 42(4):242-8. PubMed ID: 19451757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multivantaged assessment of depression in schizophrenia.
    Lindenmayer JP; Kay SR; Plutchik R
    Psychiatry Res; 1992 Jun; 42(3):199-207. PubMed ID: 1496052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD).
    Takeuchi H; Fervaha G; Lee J; Agid O; Remington G
    J Psychiatr Res; 2016 Sep; 80():87-92. PubMed ID: 27318892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Training novice raters on the Negative Symptom Assessment Scale.
    Axelrod BN; Alphs LD
    Schizophr Res; 1993 Mar; 9(1):25-8. PubMed ID: 8461268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The stress profile.
    Wheatley D
    Br J Psychiatry; 1990 May; 156():685-8. PubMed ID: 2095945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.